CP
CGON icon

CenterBook Partners’s CG Oncology CGON Stock Holding History

CenterBook Partners’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,224
Closed -$2.87M – 669
2025
Q4 		$2.87M Sell
69,224
-326,116
-82% -$13.5M 0.14% 199
2025
Q3 		$15.9M Buy
395,340
+135,241
+52% +$3.93M 0.79% 24
2025
Q2 		$6.76M Buy
260,099
+56,971
+28% +$1.37M 0.38% 65
2025
Q1 		$4.97M Sell
203,128
-32,980
-14% -$928K 0.32% 89
2024
Q4 		$6.77M Sell
236,108
-73,188
-24% -$2.5M 0.4% 72
2024
Q3 		$11.7M Sell
309,296
-26,014
-8% -$912K 0.72% 29
2024
Q2 		$10.6M Buy
335,310
+323,474
+2,733% +$11.2M 0.66% 26
2024
Q1 		$520K Buy
+11,836
New +$483K 0.04% 347

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CenterBook Partners's CGON Position: Q1 2026 in Review

CenterBook Partners sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 69,224 shares — an estimated $2.87M sold.

CenterBook Partners first reported a position in CGON in Q1 2024 and held it in 8 quarters. The position peaked at $15.9M in Q3 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • CenterBook Partners reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • CenterBook Partners sold 69,224 CG Oncology shares in Q1 2026, an estimated $2.87M.
  • CenterBook Partners first reported a position in CG Oncology in Q1 2024 and held it in 8 quarters.
  • CenterBook Partners's CG Oncology position peaked at $15.9M in Q3 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.